Sabra Healthcare REIT Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +20.4% | -8.9% | +210.3% | -5.2% | -8.9% | -1.4% | -0.3% | -3.7% | -6.3% | -1.5% | +3.6% | |
| – | -0.9% | -53.8% | +345.6% | -64.0% | -11.3% | +25.3% | +98.5% | -69.1% | -10.6% | +9.7% | -4.4% | |
| – | -88.0% | +245.2% | +1,920.9% | -90.3% | -22.2% | +51.1% | +89.6% | -56.0% | -16.3% | +46.5% | +18.3% | |
| – | -88.0% | +245.2% | +1,920.9% | -90.3% | -22.2% | +51.1% | +89.6% | -56.0% | -16.3% | +46.5% | +18.3% | |
| – | +14.9% | -44.5% | +56.7% | +0.8% | -9.8% | +23.4% | +103.9% | -72.5% | -9.5% | -1.5% | -15.5% | |
| – | – | – | – | – | – | +21.6% | +66.4% | +243.5% | -88.6% | – | – | |
| – | +23.9% | -1.5% | +198.2% | -2.4% | -8.7% | -1.1% | -2.3% | -3.9% | – | – | – | |
| – | – | – | – | -21.6% | -22.6% | -18.4% | – | – | – | – | – | |
| – | +27.0% | -2.3% | +536.6% | -21.6% | -22.6% | -18.4% | -34.7% | -25.8% | -23.0% | -11.1% | +137.8% | |
| – | +27.5% | -12.7% | +187.5% | -5.1% | -24.3% | -0.2% | +0.4% | +4.0% | -4.0% | -0.8% | +4.2% | |
| – | +10.7% | +12.7% | +158.6% | -7.5% | +14.7% | +34.5% | -2.2% | +137.2% | -31.8% | -3.0% | +50.1% | |
| – | +0.0% | -99.4% | +33,918.9% | -99.8% | +4.3% | +36,506.4% | +36.5% | -89.0% | -52.1% | +12.8% | +104.2% | |
| – | +10.7% | +12.7% | +158.6% | -7.5% | -20.5% | +94.1% | -2.2% | -0.5% | -48.1% | -8.1% | – | |
| – | +43.4% | -9.6% | +59.5% | -54.9% | -2.3% | +1,998.1% | +0.9% | -3.5% | +0.4% | -0.4% | +0.0% | |
| – | +11.9% | -3.6% | +238.0% | -5.3% | +7.3% | -2.3% | -0.9% | -9.6% | -8.3% | -2.2% | +2.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +33.2% | +4.9% | +61.5% | +68.9% | +5.3% | +10.2% | +5.7% | +5.4% | +0.8% | +1.4% | +3.6% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.